Puma Biotechnology, Inc.'s (NASDAQ:PBYI) US$24m market value fall may be overlooked by institutional investors after a year of 1.6% returns - Simply Wall St News
Puma Biotechnology (PBYI) Presents At Barclays Global Healthcare Virtual Conference (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology: Nerlynx Peak Sales Estimates Have Come Down, But The Intense Selling Still Makes This A Buy (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
Do Insiders Own Lots Of Shares In Puma Biotechnology, Inc. (NASDAQ:PBYI)? | Nasdaq
Puma Biotechnology Reports Third Quarter 2022 Financial Results | Business Wire
Puma Biotechnology
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat | Nasdaq
Puma Biotechnology: Waiting For Commercial Numbers To Catch Up To Clinical Data (NASDAQ:PBYI) | Seeking Alpha